<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType><periodOfReport>2003-08-14</periodOfReport>
    <issuer>
        <issuerCik>0000944763</issuerCik>
        <issuerName>ENCORE MEDICAL CORP</issuerName>
        <issuerTradingSymbol>ENMC</issuerTradingSymbol></issuer><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000923421</rptOwnerCik>
            <rptOwnerName>WILKERSON L JOHN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O GALEN ASSOCIATES</rptOwnerStreet1>
            <rptOwnerStreet2>610 FIFTH AVENUE</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
<isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>1</isTenPercentOwner><isOther>0</isOther></reportingOwnerRelationship></reportingOwner><derivativeTable><derivativeTransaction><securityTitle><value>Warrants to Purchase Common Stock</value></securityTitle><conversionOrExercisePrice><value>.01</value></conversionOrExercisePrice><transactionDate><value>2003-08-14</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>J</transactionCode><equitySwapInvolved>0</equitySwapInvolved><footnoteId id="F3"/></transactionCoding><transactionAmounts><transactionShares><value>502129</value></transactionShares><transactionPricePerShare><footnoteId id="F3"/></transactionPricePerShare><transactionAcquiredDisposedCode><value>A</value></transactionAcquiredDisposedCode></transactionAmounts><exerciseDate><value>2003-08-14</value></exerciseDate><expirationDate><value>2009-02-08</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>502129</value></underlyingSecurityShares></underlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>502129</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureOfOwnership><value>By Galen Partners III, L.P. </value><footnoteId id="F1"/></natureOfOwnership></ownershipNature></derivativeTransaction><derivativeTransaction><securityTitle><value>Warrants to Purchase Common Stock</value></securityTitle><conversionOrExercisePrice><value>.01</value></conversionOrExercisePrice><transactionDate><value>2003-08-14</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>J</transactionCode><equitySwapInvolved>0</equitySwapInvolved><footnoteId id="F3"/></transactionCoding><transactionAmounts><transactionShares><value>45449</value></transactionShares><transactionPricePerShare><footnoteId id="F3"/></transactionPricePerShare><transactionAcquiredDisposedCode><value>A</value></transactionAcquiredDisposedCode></transactionAmounts><exerciseDate><value>2003-08-14</value></exerciseDate><expirationDate><value>2009-02-08</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>45449</value></underlyingSecurityShares></underlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>45449</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureOfOwnership><value>By Galen Partners International III, L.P.</value><footnoteId id="F2"/></natureOfOwnership></ownershipNature></derivativeTransaction></derivativeTable><footnotes><footnote id="F1">By Galen Partners III, L.P. (&quot;Galen III&quot;).  The reporting person is one of several managing members of the sole general partner of Galen III.  Pursuant to Instruction 4(b)(iv) of Form 4, the reporting person has elected to report as indirectly beneficially owned the entire number of securities owned by such limited partnership.  The reporting person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein, and/or that are not actually distributed to him.</footnote><footnote id="F2">By Galen Partners International III, L.P. (&quot;Galen Intl&quot;).  The reporting person is one of several managing members of the sole general partner of Galen Intl.  Pursuant to Instruction 4(b)(iv) of Form 4, the reporting person has elected to report as indirectly beneficially owned the entire number of securities owned by such limited partnership.  The reporting person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein, and/or that are not actually distributed to him.</footnote><footnote id="F3">The warrants were assigned to Galen III and Galen Intl by the Issuer's lender pursuant to a pre-existing agreement between Gallen III, Galen Intl and the lender.  The lender had agreed to transfer these warrants if certain events occurred and a specified portion of the indebtedness owed by the Issuer to the lender was prepaid.</footnote></footnotes><remarks/><ownerSignature><signatureName>L. John Wilkerson</signatureName><signatureDate>2003-12-18</signatureDate></ownerSignature></ownershipDocument>

